Smith & Wesson (SWBI) faces a rating downgrade as analysts reassess its market potential following disappointing sales figures. Once viewed as a promising investment during 2024’s political turmoil, expectations for increased gun sales have not materialized, leading to a more cautious outlook for the renowned firearms manufacturer.
Despite initial optimism, the company’s fundamentals remain stagnant more than a year later, prompting scrutiny ahead of the upcoming Q1 results. Investors are particularly focused on improvements to the balance sheet before any potential re-evaluation of the stock to a Buy rating can occur.
Read full story at seekingalpha.com
